DROPS
Composition:
alpha-Ketoglutaricum acidum 6X Adrenalinum 6X Ambra grisea 6X Artery 6X Cerebellum 6X Chininum salicylicum 6X Cocculus indicus 4X Conium maculatum 3X Fumaricum acidum 6X Malic acid 6X Melatonin 4C Petroleum 8X Placenta totalis 6X Pteridium aquilinum 8X Pyridoxinum hydrochloricum 6X Quinhydrone 6X Tabacum 6X Thiaminum hydrochloricum 4X Package size:
Indications:
Vertiginous syndromes of different etiology: vascular,
vestibular, or degenerative.
Dosage:
20 drops twice a day.
Acute dosage: In acute phase 10 drops every 30 minutes for 2-3 hours.
Package sizes:
30 ml / 1.0 fl. oz. bottle with dropper. For oral use.
Pharmacological notes:
Spasmolytic and antisclerotic
action on encephalous vases*.
Cocculus indicus 4X*
Conium mac. 3X* Increase of Adrenalin secretion*.
Ambra grisea 6X** Stimulation of cerebral functions**.
Chininum sal. 6X***
Petroleum 8X*** Control on the dizziness
Pteridium aquil. 8X*** symptomatology***.
Cerebellum 6X****
Transmission improvement
Thiaminum hydr. 4X****
between cerebellar centers
Pyridoxinum 6X****
and internal ear****.
Metabolic reactivation
NEUROLOGIC
of the cells in the internal ear.
AETIOLOGY
(SNC-SNP)
NEUROLOGIC
Fumaricum ac. 6X DEGENERATIVE Melatonin 4C*
AETIOLOGY
alpha-ketoglutaricum ac. 6X Adrenalinum 6X**
AETIOLOGY
Malic ac. 6X (VNS)
Quinhydrone 6X
VASCULAR
AETIOLOGY Synchronization of the
neuro-endocrine function*.
Adrenergic stimulation
on vases and CNS**.
Angiospasm reduction Tabacum 6X*
Artery 6X**
Antidegenerative
Placenta tot. 6X**
support of the vases**.
Rational Structure according to GUNA-Method:
Spasmolytic and antisclerotic
action on encephalous vases*.
Cocculus indicus 4X*
Conium mac. 3X* Increase of Adrenalin secretion*.
Ambra grisea 6X** Stimulation of cerebral functions**.
Chininum sal. 6X***
Petroleum 8X*** Control on the dizziness
Pteridium aquil. 8X*** symptomatology***.
Cerebellum 6X****
Transmission improvement
Thiaminum hydr. 4X****
between cerebellar centers
Pyridoxinum 6X****
and internal ear****.
Metabolic reactivation
NEUROLOGIC
of the cells in the internal ear.
AETIOLOGY
(SNC-SNP)
NEUROLOGIC
Fumaricum ac. 6X DEGENERATIVE Melatonin 4C*
AETIOLOGY
alpha-ketoglutaricum ac. 6X Adrenalinum 6X**
AETIOLOGY
Malic ac. 6X (VNS)
Clinical notes & Combinations:
Guna-Dizzy + Guna-Cell + Guna-Fem/ Guna-Male: vertigo syndromes in patients suffering from light head,
dizziness, motion sickness, professional stress, drug side effects, and general decay associated with aging.
Guna-Dizzy + Guna-Arthro: vertigo syndrome of possible arthrotic origin.
Complexes
GUNA – DIZZY
Product Link: https://urenus.com/en-us/products/dizzy-30ml-drops